title: [Antiparasitic therapy of children in Equatorial Africa].
abstract: Parasitic infections are endemic in children in Africa, making eradication an impossibility. Therapy is directed towards the individual manifesting an imbalance in the host-parasite relationship. Sanitation education is often disappointing, and until effective vaccines are developed, drug therapy remains the only worthwhile intervention. In order for a drug to be used on a mass campaign basis, financial considerations and side effects are of primary importance. Mefloquine has been shown to be a useful second line drug for chloroquine resistant strains of malaria in our Parasitology department. Benzimidazoles in a single dose are useful for intestinal nematode infections. New drugs are now available for schistosomiasis, filariasis, and protozoan infections.
mesh_terms: D002648:Child; D005681:Gabon; D006373:Helminthiasis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008288:Malaria / Q000188:drug therapy; D009349:Nematode Infections / Q000188:drug therapy; D011528:Protozoan Infections / Q000188:drug therapy* / Q000453:epidemiology; D012552:Schistosomiasis / Q000188:drug therapy
vernacular_title: La thérapeutique antiparasitaire de l'enfant en Afrique équatoriale.